Suicidal misophonia: a case report
Open accessThe DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index; 4 of the 15 sources its claims cite were checked for support.
Abstract
Misophonia is still an unclassified disorder and means literally “strong dislike (hate) of sounds”. In this paper, we present a case report of an adolescent female who had misophonia that was complicated with two non-fatal suicide attempts. She presented with anxiety features and started to follow up for three years. Assessment of the level of misophonia for a year using Amsterdam Misophonia Scale (A-MISO-S) showed an extreme degree soon after the second suicide attempt. Initially, psychotherapy was noticed to be ineffective due to her poor motivation. Escitalopram was added to the management plan and improvement was reported in the depressive symptoms and obsessional thoughts of misophonia but were intolerable eventually because of the weight gain. Therefore, it was switched into Fluoxetine and Bupropion but six weeks later she attempted her second suicide by Bupropion overdose. At that point, the psychiatrist, the patient and her parents agreed to continue therapy with non-psychopharmacological treatment. Gradually she became more engaged in psychotherapy sessions after noticing its effectiveness. It was concluded that significant improvement of misophonia was reported when she was treated by Selective Serotonin Reuptake Inhibitors (SSRI) namely Escitalopram or Fluoxetine, motivated in psychotherapy sessions, adapted good coping strategies, decreased her dysfunctional challenging behaviour, rejoined social interaction and activity in her life, was more insightful and aware about her illness and developed self-acceptance. © 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Overview
CoChat Summary
TL;DR
This case report describes an 18-year-old female in Bahrain with misophonia, anxiety, depression, and two non-fatal suicide attempts. Her misophonia severity was extreme on the Amsterdam Misophonia Scale after the second attempt and improved by 47.8% over one year with psychotherapy and non-psychopharmacological management after medication trials were complicated by weight gain and overdose.
Key findings
- A-MISO-S total was 23 (extreme) soon after the second suicide attempt, 16 at 3 months, and 12 at 12 months, corresponding to a total 47.8% reduction during one-year adherence to the management plan.
- Escitalopram 20 mg/day and later fluoxetine 20–40 mg/day plus bupropion 150 mg/day were associated with improvement in depressive and obsessional misophonia symptoms, but escitalopram/mirtazapine was stopped after weight increased from 51 kg to 54 kg and then 59 kg; she developed atypical bulimia nervosa and later attempted suicide by taking around 30 bupropion tablets.
- Psychotherapy was initially ineffective due to poor motivation; after the second suicide attempt, she engaged in 20 psychotherapy sessions over one year and used earplugs, headsets, music, self-distraction, and positive internal dialogue. Severity fell from extreme to severe (30.4% reduction) and then severe to moderate (additional 17.4% reduction).
- SCID-I at initial presentation revealed no mental disorders; MMPI in 12/2018 reported no personality disorders; BMI was 19.5; family history included OCD in her father and several relatives, with no family member reported to have misophonia.
Methods
- Single case report of an 18-year-old female student living with her parents in Bahrain, followed irregularly in the Anxiety Department for three years, with consent from the patient and her father.
- Assessments included SCID-I at initial presentation in 12/2015, A-MISO-S soon after the second suicide attempt in 12/2017 and at 3 and 12 months post-suicide, and MMPI in 12/2018.
- Management included psychoeducation, psychotherapy, escitalopram, mirtazapine, fluoxetine, bupropion, and eventually continuation with non-psychopharmacological treatment.
Limitations
- The paper states there is still no study on the validity or reliability of the A-MISO-S, no study yet on the effectiveness of psychotropics in misophonia, and that it could not identify whether improvement on escitalopram or fluoxetine was a direct effect or indirect through treating comorbid depression and anxiety.
- Evident from the text: this is a single case report with no control group, irregular follow-up, multiple concurrent treatments and psychosocial changes, so causality cannot be established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
4 Valid · 0 Not valid · 10 Not checked · 18 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The severity of misophonia symptoms reduced (from extreme to severe) with a reduction of 30.4% by engaging in psychotherapy sessions, adapting a new positive approach in coping with her condition namely the use of Earplugs, Headsets and Music, focusing her conscious toward her own sounds, self-distraction and positive internal dialogue [3].”
What the sources say
- Partly supportedcites [3] [3] Edelstein M, Brang D, Rouw R, et al. Misophonia: physiological investigations and case descriptions. Front Hum Neurosci. 2013;25:3 -11. doi:10.3389/ fnhum.2013.00296. - sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a causeSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Interestingly, a recent study in Singapore on psychiatric patients with misophonia found that anxiety level could predict the severity of misophonia [14].”
What the sources say
- Supportedcites [14] [14] Quek TC, Ho C, Choo CC, et al. Misophonia in Singaporean psychiatric patients: a cross-sectional study. Int J Environ Res Public Health. 2018;15:1410. doi:10.3390/ijerph15071410. - source
The Results (§3.3) report that anxiety remained significantly associated with misophonia severity in multivariate regression among Singaporean psychiatric patients. This supports “could predict” in the statistical sense; the paper does not establish that anxiety predicts future severity. (LLM, conf=0.90)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In our case, we observed an improvement in her condition while on Escitalopram or Fluoxetine.”
plainstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but were intolerable eventually because of the weight gain.”
- Also stated in: § Case presentation · p. 3 · plain
“Escitalopram 20 mg/day was discontinued because she felt over-weighted”
plainstates a causeSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Case presentation · p. 3 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, it was switched into Fluoxetine and Bupropion but six weeks later she attempted her second suicide by Bupropion overdose.”
- Also stated in: § Case presentation · p. 4 · plain
“She tried to end her life by taking around 30 tablets of Bupropion on (12/2017).”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Case presentation · p. 4 · plain
6 more claims
Create a free account to see all 32 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 10
- The quote only partly states this claim. 5
- Probably not a substantial claim. 14
Citations
Cites
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 1×
“etine paradoxical side effect, acted as an emotion-regulation behaviour for her misophonia [17].”
BackgroundMisophonia: Diagnostic Criteria for a New Psychiatric Disorder
Schröder, A., Vulink, N., & Denys, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054706 · Cited by 410 · cited 5×
“It also been reported that patients with misophonia may have features of Intermittent explosive disorder with impulsive aggressions and rarely to lose control [2].”
BackgroundMethodInfluentialMisophonia: Incidence, Phenomenology, and Clinical Correlates in an Undergraduate Student Sample
Wu, M. S., Lewin, A. B., Murphy, T. K., & Storch, E. A. (2014) · Journal of Clinical Psychology · doi:10.1002/jclp.22098 · Cited by 360 · cited 2×
“the prevalence of misophonia showed that it can reach up to 20% among undergraduate students [6].”
BackgroundMisophonia: Physiological investigations and case descriptions
Edelstein, M., Brang, D., Rouw, R., & Ramachandran, V. S. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00296 · Cited by 330 · cited 3×
“ing others and asking them to stop producing sounds, decrease in ability to concentrate at school or in the workplace, an inability to meet new friends and to maintain an ongoing relation or limit social activities such as eating meals with others [3,5].”
BackgroundTreatments for decreased sound tolerance (hyperacusis and misophonia)
Jastreboff, M., & Jastreboff, P. (2014) · Seminars in Hearing · doi:10.1055/s-0034-1372527 · Cited by 245 · cited 1×
“Interestingly we believe that our patient had implemented some of these techniques by her own [20].”
BackgroundZhou, X., Wu, M. S., & Storch, E. A. (2017) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2017.05.001 · Cited by 177
Cognitive behavioral therapy is effective in misophonia: An open trial
Schröder, A. E., Vulink, N. C., van Loon, A. J., & Denys, D. A. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.017 · Cited by 139 · cited 1×
“In one of the studies CBT reported to improve 48% of patients with misophonia [19].”
BackgroundMisophonia: Current perspectives
Cavanna, A. E., & Seri, S. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s81438 · Cited by 135 · cited 1×
“There are different views on where shall misophonia be listed and if it is a symptom or psychiatric disorder [11].”
BackgroundA brief course of cognitive behavioural therapy for the treatment of misophonia: a case example
Bernstein, R. E., Angell, K. L., & Dehle, C. M. (2013) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x13000172 · Cited by 115
Misophonia: A new mental disorder?
Taylor, S. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.05.003 · Cited by 109 · cited 1×
“ing others and asking them to stop producing sounds, decrease in ability to concentrate at school or in the workplace, an inability to meet new friends and to maintain an ongoing relation or limit social activities such as eating meals with others [3,5].”
Background
Research works printed but not linked: 2
- [1] Jastrebo ff MM, Jastrebo ff PJ. Components of decreased sound tolerance: hyperacusis, misophonia, phonophobia. ITHS News Lett. 2001;2:5 -7. -
- [8] First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition. (SCID-I/P). New York (NY): Biometrics Research: New York State Psychiatric Institute; November 2002. -
Cited by
Misophonia in the UK: Prevalence and norms from the S-Five in a UK representative sample
Vitoratou, S., Hayes, C., Uglik‐Marucha, N., Pearson, O. P., Graham, T., & Gregory, J. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282777 · Cited by 103
Vitoratou, S., Uglik-Marucha, N., Hayes, C., & Gregory, J. (2021) · Psych · doi:10.3390/psych3040041 · Cited by 70
“The impact of misophonia is not contained to moments of being bothered by sounds, with reports of anticipatory anxiety about eating situations [21], rumination and replaying events [20], and beliefs about continuing to be bothered by sounds and being impacted negatively in the future [18].”
BackgroundInfluentialDoes context matter in misophonia? A multi-method experimental investigation
Siepsiak, M., Vrana, S. R., Rynkiewicz, A., Rosenthal, M. Z., & Dragan, W. Ł. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.880853 · Cited by 52
A systematic review of treatments for misophonia
Mattson, S. A., D’Souza, J. M., Wojcik, K. D., Guzick, A. G., Goodman, W. K., & Storch, E. A. (2023) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2023.100104 · Cited by 47
“Of the patients in these studies (n = 7), all were young females ranging from 16 to 22 years old and the most common reaction was anger [1,2,3,38,57].”
A longitudinal investigation of quality of life and negative emotions in misophonia
Dibb, B., & Golding, S. E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.900474 · Cited by 31
Metadata
- Authors
- Alekri, J., & Al Saif, F.
- Affiliations
- Ministry of Health (BH)
- Psychiatry Training Resident, Psychiatric Hospital, Ministry of Health, Manama, Kingdom of Bahrain
- Venue
- Psychiatry and Clinical Psychopharmacology
- Publisher
- Taylor & Francis
- Published
- 2019-03-26
- Volume
- 29
- Issue
- 2
- Pages
- 232-237
- ISSN
- 2475-0573 (ISSN-L)
- 2475-0581
- OpenAlex
- W2924826112
- Semantic Scholar
- 4cfbd3d3d70b32f457ff1d1aeda827ae09e7341c
- Cited by
- 35
- References
- 17
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 11 · 2022: 9 · 2021: 3 · 2019: 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Psychiatry and Clinical Psychopharmacology (publishedVersion, cc-by)
- Psychiatry and Clinical Psychopharmacology (publishedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Physical Sciences › Physics and Astronomy › Acoustics and Ultrasonics › Noise Effects and Management
- Keywords
- misophonia, suicide attempts, adolescents, selective serotonin reuptake inhibitors, escitalopram, fluoxetine, bupropion, adverse drug reactions, psychotherapy, anxiety, self-acceptance, coping strategies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-26, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-26 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suicidal misophonia: a case report. https://app.cochat.ai/papers/10.1080/24750573.2019.1597585
- The paper
- Alekri, J., & Al Saif, F. (2019). Suicidal misophonia: a case report. Psychiatry and Clinical Psychopharmacology. https://doi.org/10.1080/24750573.2019.1597585
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



